Metraipolis › archive › dc_e9bd69693b03

Antiglycation approach in selected autoimmune diseases: Where do we stand? — Europe PMC PMID:42777665

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42777665
DOI
10.1016/j.redox.2026.104410
License (as archived)
solo-consultazione
Archived
2026-10-07T23:35:55.653Z
SHA-256 of the archived text
99fe6596484d31ed8bd8c152a84af30484b1c5759126a227111c73a7e58fb94f
Stable URL of this page
https://metraipolis.com/documento/dc_e9bd69693b03

How to cite

Antiglycation approach in selected autoimmune diseases: Where do we stand? — Europe PMC PMID:42777665 — Europe PMC (en), https://europepmc.org/article/MED/42777665 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9bd69693b03 (Metraipolis archive dc_e9bd69693b03, sha256 99fe6596484d31ed8bd8c152a84af30484b1c5759126a227111c73a7e58fb94f)
BibTeX
@misc{dce9bd69693b03,
  title = {Antiglycation approach in selected autoimmune diseases: Where do we stand? — Europe PMC PMID:42777665},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42777665},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9bd69693b03; sha256 99fe6596484d31ed8bd8c152a84af30484b1c5759126a227111c73a7e58fb94f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42777665. Agents can read the archived copy with the MCP tool read_document.